Urgostart Contact Layer

UrgoStart Contact is a sterile, non-adhesive and non-occlusive wound contact layer containing Urgo Medical's TLC-NOSF Healing Matrix, designed for the management of chronic and hard-to-heal wounds.

The highly conformable contact layer is particularly suitable for granulating and epithelialising wounds, including wounds in difficult-to-dress areas, deep wounds and cavities. It can be cut to shape and used underneath an appropriate secondary absorbent dressing.

The TLC-NOSF Healing Matrix helps reduce excess matrix metalloproteinases (MMPs), supporting a wound environment favourable to healing while maintaining moisture and allowing gentle, atraumatic dressing removal.

Key features:

• Advanced wound contact layer
• Contains TLC-NOSF Healing Matrix
• Helps reduce excess matrix metalloproteinases (MMPs)
• Supports progression towards wound closure
• Non-adhesive
• Non-occlusive
• Highly flexible and conformable
• Suitable for difficult-to-dress anatomical areas
• Suitable for deep and cavity wounds
• Suitable for granulating and epithelialising wounds
• Maintains a moist wound-healing environment
• Designed for gentle, atraumatic removal
• Can be cut to shape with sterile scissors
• Can be used underneath a wide range of secondary dressings
• Can be combined with a superabsorbent dressing for highly exuding wounds
• Compatible with compression therapy where clinically prescribed
• Can remain in place for up to 7 days
• Sterile
• Single use
• Medical device

TLC-NOSF Healing Matrix:

UrgoStart Contact contains Urgo Medical's patented TLC-NOSF technology.

TLC-NOSF combines Technology Lipido-Colloid with Nano-OligoSaccharide Factor (NOSF).

Chronic wounds can contain excessive levels of matrix metalloproteinases, enzymes which can degrade proteins and extracellular matrix components required for normal tissue repair.

The TLC-NOSF Healing Matrix helps reduce excess MMP activity and supports a wound environment more favourable to healing.

It also helps:

• Maintain an appropriately moist wound environment
• Protect newly forming tissue
• Minimise adherence to the wound bed
• Support gentle dressing removal

Dressing construction:

UrgoStart Contact is a highly conformable polyester mesh contact layer impregnated with the TLC-NOSF Healing Matrix.

Unlike UrgoStart or UrgoStart Plus Pad, it does not contain an absorbent foam or poly-absorbent pad.

It therefore requires an appropriate secondary absorbent dressing selected according to the amount of wound exudate.

This makes UrgoStart Contact particularly useful when the clinician wishes to combine TLC-NOSF technology with a separately selected absorbent dressing.

Suitable wound types include:

UrgoStart Contact is indicated for wounds including:

• Leg ulcers
• Venous leg ulcers
• Diabetic foot ulcers
• Pressure injuries / pressure ulcers
• Other chronic wounds at risk of prolonged healing

It is particularly suitable for:

• Granulating wounds
• Epithelialising wounds
• Deep wounds
• Cavity wounds
• Wounds in difficult-to-dress locations

UrgoStart Contact can be used underneath any suitable secondary dressing.

For highly exuding wounds, it can be combined with an appropriate superabsorbent dressing.

The underlying cause of the wound must always be appropriately treated.

For example:

• Compression therapy may be required for venous leg ulcers
• Off-loading may be required for diabetic foot ulcers
• Pressure redistribution is required for pressure injuries

How to use:

UrgoStart Contact should be applied by, or according to the advice of, an appropriately trained healthcare professional.

Before application:

1. Wash or disinfect hands and use appropriate clinical gloves.
2. Prepare and clean the wound according to the usual wound-management protocol.
3. Debride the wound where clinically required.
4. Gently dry the surrounding skin.
5. Select an appropriate secondary absorbent dressing according to the level of exudate.
6. Check that the sterile UrgoStart Contact pouch is intact before opening.

Application:

1. Open the sterile pouch carefully.
2. Put on clean disposable medical gloves.
3. Remove UrgoStart Contact from its packaging.
4. If required, cut the dressing to the appropriate size or shape using sterile scissors.
5. Remove the protective films.
6. Apply UrgoStart Contact directly to the wound bed.
7. Cover with a suitable secondary absorbent dressing.
8. Secure the secondary dressing using an appropriate fixation system if required.
9. Apply compression therapy or an off-loading system where clinically prescribed.

Deep and cavity wounds:

UrgoStart Contact may be used in deep or cavity wounds where clinically appropriate.

When placing the contact layer into a deep wound or cavity:

• Ensure the dressing is positioned without excessive packing
• Leave part of the dressing visible outside the wound
• This helps ensure that the complete dressing can be identified and removed at the next dressing change

Do not leave fragments of dressing within the wound.

Handling precaution:

UrgoStart Contact may adhere to latex gloves.

If latex gloves are used, moistening them with water or physiological saline may make handling easier.

Alternatively, avoid direct contact with the coated surface where possible.

Dressing changes:

Urgo Medical recommends changing UrgoStart Contact approximately:

• Every 2–4 days

The interval can be adjusted according to:

• Wound condition
• Exudate level
• Condition of the secondary dressing
• Condition of the surrounding skin
• Clinical assessment

The contact layer may remain in place for up to 7 days where clinically appropriate.

Treatment may continue until complete wound healing according to the patient's wound-management plan.

Change earlier if:

• The secondary dressing becomes saturated
• Exudate leaks
• The dressing becomes displaced
• The wound requires reassessment
• Signs of infection or deterioration develop

Important information:

UrgoStart Contact is intended primarily for granulating and epithelialising wounds.

It is not intended for fully fibrinous wounds where the wound bed is completely covered by yellow slough.

Do not use on wounds containing dry necrotic black tissue / eschar unless appropriately managed and specifically assessed by a healthcare professional.

Contraindications:

Do not use UrgoStart Contact on:

• Malignant wounds
• Fistula wounds
• Wounds on mucous membranes
• Patients with known hypersensitivity to:
  • TLC dressings
  • TLC-NOSF dressings
  • Carboxymethylcellulose (CMC)

In the absence of sufficient clinical data, UrgoStart Contact is not recommended for wounds associated with epidermolysis bullosa.

Infection:

UrgoStart Contact does not replace appropriate treatment of wound infection.

Seek clinical assessment if there are signs or symptoms including:

• Increasing redness
• Swelling
• Heat around the wound
• Increasing pain
• Fever
• Increasing wound size
• Offensive odour
• Increasing or excessive exudate

Appropriate treatment of infection should be instituted where required.

Overgranulation:

If excessive raised granulation tissue develops before or during treatment, the wound should be assessed by an appropriately trained healthcare professional.

Single-use information:

UrgoStart Contact dressings are:

• Sterile
• Individually packaged
• Single use only

Do not:

• Reuse
• Re-sterilise
• Use if the sterile pouch is damaged or previously opened
• Use after the expiry date

Product type: Advanced Wound Contact Layer / Protease-Modulating Dressing

Technology: TLC-NOSF Healing Matrix

Construction: Polyester mesh contact layer

Adhesive: No

Occlusive: No

Absorbent pad: No

Secondary dressing required: Yes

Can be cut: Yes

Suitable wound stage: Granulation and epithelialisation

Suitable for cavity wounds: Yes, where clinically appropriate

Compatible with compression therapy: Yes, where prescribed

Typical dressing-change interval: Every 2–4 days

Maximum wear time: Up to 7 days

Sterile: Yes

Single use: Yes

Current UK sizes and codes:

• 5cm × 7cm
  • Pack size: 10 dressings
  • Manufacturer code: 550276
  • PIP code: 339-8971
  • NHS code: EKB081
  • BNF / dm+d code: 20031600052
• 10cm × 10cm
  • Pack size: 10 dressings
  • Manufacturer code: 550278
  • PIP code: 386-1390
  • NHS code: EKB087
  • BNF / dm+d code: 20031600131
• 15cm × 20cm
  • Pack size: 10 dressings
  • Manufacturer code: 550277
  • PIP code: 386-1382
  • NHS code: EKB088
  • BNF / dm+d code: 20031600132

Manufacturer: Urgo Medical / Urgo Ltd

UrgoStart Contact should be selected and used according to the wound type, wound-bed condition, exudate level and overall wound-management plan established by an appropriately trained healthcare professional.